Meiji Yasuda Life Insurance’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-6,707
Closed -$367K 231
2025
Q3
$367K Hold
6,707
0.01% 203
2025
Q2
$356K Hold
6,707
0.01% 206
2025
Q1
$290K Sell
6,707
-265
-4% -$13.4K 0.01% 221
2024
Q4
$392K Hold
6,972
0.01% 212
2024
Q3
$475K Hold
6,972
0.01% 195
2024
Q2
$295K Hold
6,972
0.01% 222
2024
Q1
$481K Hold
6,972
0.01% 217
2023
Q4
$516K Hold
6,972
0.01% 217
2023
Q3
$476K Hold
6,972
0.01% 215
2023
Q2
$655K Sell
6,972
-252
-3% -$19.7K 0.02% 204
2023
Q1
$490K Buy
7,224
+329
+5% +$21.1K 0.01% 217
2022
Q4
$341K Hold
6,895
0.01% 251
2022
Q3
$224K Hold
6,895
0.01% 265
2022
Q2
$272K Hold
6,895
﹤0.01% 260
2022
Q1
$482K Buy
6,895
+326
+5% +$23.8K 0.01% 199
2021
Q4
$511K Hold
6,569
0.01% 222
2021
Q3
$627K Hold
6,569
0.01% 190
2021
Q2
$817K Hold
6,569
0.02% 165
2021
Q1
$866K Hold
6,569
0.02% 158
2020
Q4
$870K Sell
6,569
-831
-11% -$100K 0.02% 154
2020
Q3
$754K Hold
7,400
0.02% 163
2020
Q2
$643K Buy
+7,400
New +$591K 0.03% 170

Other funds holding EXAS

Meiji Yasuda Life Insurance's EXAS Position: Q4 2025 in Review

Meiji Yasuda Life Insurance sold out of Exact Sciences (EXAS) in Q4 2025, closing a stake of 6,707 shares — an estimated $367K sold.

Meiji Yasuda Life Insurance first reported a position in EXAS in Q2 2020 and held it in 22 quarters. The position peaked at $870K in Q4 2020. 711 funds tracked by Wall St. Rank hold EXAS as of Q4 2025.

  • Meiji Yasuda Life Insurance reported no remaining Exact Sciences position as of Q4 2025 after selling out during the quarter.
  • Meiji Yasuda Life Insurance sold 6,707 Exact Sciences shares in Q4 2025, an estimated $367K.
  • Meiji Yasuda Life Insurance first reported a position in Exact Sciences in Q2 2020 and held it in 22 quarters.
  • Meiji Yasuda Life Insurance's Exact Sciences position peaked at $870K in Q4 2020.
  • 711 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2025.

Based on Meiji Yasuda Life Insurance's 13F filing for Q4 2025, filed 11 Feb 2026.